Targeting Negative Surface Charges of Cancer Cells by Multifunctional Nanoprobes

Bingdi Chen1, Wenjun Le1, Yilong Wang1

  • 1The Institute for Translational Nanomedicine, Shanghai East Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai, 200120, China;

Theranostics
|August 30, 2016
PubMed

Insights

New nanoprobes specifically target cancer cells by detecting their unique negative surface charge, which is linked to high glucose metabolism. This discovery offers a novel, biomarker-free method for cancer cell detection and isolation.

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Oncology

Background:

  • Cancer cells exhibit distinct surface properties compared to normal cells.
  • Targeting cancer cells often relies on specific molecular biomarkers.
  • Developing biomarker-free cancer detection methods is a significant challenge.

Purpose of the Study:

  • To develop and characterize novel nanoprobes for biomarker-free cancer cell targeting.
  • To investigate the surface electrostatic properties of various cancer cell lines.
  • To explore the relationship between cancer cell metabolism and surface charge.

Main Methods:

  • Development of electrostatically charged, fluorescent, and superparamagnetic nanoprobes.
  • Characterization of surface electrostatic properties using nanoprobes with varying charges.
  • Quantification of cancer cell surface charge via magnetic cell capture percentages.
  • Analysis of glucose metabolism and lactate secretion in cancer cells.

Main Results:

  • Twenty-two cancer cell lines specifically bound to positively charged nanoprobes, unlike normal cells.
  • Cancer cell surface charge is quantifiable and influenced by glucose metabolism.
  • Elevated glycolysis leads to lactate secretion, generating a negative surface charge on cancer cells.
  • A unique surface electrostatic pattern was identified in metabolically active cancer cells.

Conclusions:

  • Positively charged nanoprobes can specifically target cancer cells without biomarkers.
  • Cancer cell surface charge is a metabolic byproduct, offering a novel detection strategy.
  • These findings enable the recovery of cancer cells from blood and other solutions based on their unique electrostatic signature.